Publication History

Google Scholar | PubMed Bibliography | ORCID

Yip WCO, Du E, Morello CM, Bounthavong M. Comparison between in-person, telehealth, and combination visits among veterans treated in a pharmacist-led diabetes management clinic. J Am Pharm Assoc (2003). 2024 May 10:102121. doi: 10.1016/j.japh.2024.102121. Epub ahead of print. PMID: 38735391. (link)

Sepassi A, Li M, Suh K, Stottlemyer B, Bounthavong M. Association of Opioid and Concurrent Benzodiazepine, Skeletal Muscle Relaxant, and Gabapentinoid Usage on Healthcare Expenditure and Resource Utilization: A Serial Cross-Sectional Study, 2009 to 2019. Subst Use Addctn J. 2024 May 8:29767342241247372. doi: 10.1177/29767342241247372. Epub ahead of print. PMID: 38717121. (link)

Williams EC, Frost MC, Bounthavong M, Edmonds AT, Lau MK, Edelman EJ, Harvey MA, Christopher MLD. Implementation of Opioid Safety Efforts: Influence of Academic Detailing on Adverse Outcomes Among Patients in the Veterans Health Administration. Subst Use Addctn J. 2024 Apr 18:29767342241243309. doi: 10.1177/29767342241243309. Epub ahead of print. PMID: 38634339. (link)

Bounthavong M, Smith JP, Guerra MB, Stout MP, Chen AM, Wells DL, Almeida AG, Morillo CM, Christopher MLD. Burnout assessment among pharmacist-academic detailers at the US Veterans Health Administration. J Am Pharm Assoc (2003). 2024 Mar 29:102080. doi: 10.1016/j.japh.2024.102080. Epub ahead of print. PMID: 38556245. (link)

Bounthavong M. Despair and hope: Is the retail community pharmacy workforce in danger of becoming a monopsony labor market? J Am Pharm Assoc (2003). 2024 May-Jun;64(3):102039. doi: 10.1016/j.japh.2024.02.012. Epub 2024 Feb 14. PMID: 38360112. (link)

Miller WA, Gordon AJ, Clothier BA, Ackland PE, Bounthavong M, Garcia C, Kenny ME, Noorbaloochi S, Hagedorn HJ. Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study. Implement Res Pract. 2023 Sep 14;4:26334895231199463. doi: 10.1177/26334895231199463. PMID: 37790176; PMCID: PMC10504828. (link)

Garcia CC, Bounthavong M, Gordon AJ, Gustavson AM, Kenny ME, Miller W, Esmaeili A, Ackland PE, Clothier BA, Bangerter A, Noorbaloochi S, Harris AHS, Hagedorn HJ. Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. Implement Sci Commun. 2023 Aug 10;4(1):91. doi: 10.1186/s43058-023-00482-8. PMID: 37563672; PMCID: PMC10413546. (link)

Joyce VR, Oliva EM, Garcia CC, Trafton J, Asch SM, Wagner TH, Humphreys K, Owens DK, Bounthavong M. Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Addiction. 2023 Nov;118(11):2203-2214. doi: 10.1111/add.16289. Epub 2023 Jul 19. PMID: 37465971. (link)

Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review. J Am Pharm Assoc (2003). 2023 Jul-Aug;63(4):1138-1149. doi: 10.1016/j.japh.2023.05.015. Epub 2023 May 18. PMID: 37207713. (link)

Bounthavong M. Is Providing Medications for Opioid Use Disorder to Incarcerated Individuals a Cost-effective Strategy? JAMA Netw Open. 2023 Apr 3;6(4):e237001. doi: 10.1001/jamanetworkopen.2023.7001. PMID: 37058311. (link)

Alabbas SA, Jiang R, Au A, Vu M, Moore VR, Cunningham FE, Stroupe K, Bounthavong M, Glassman PA, Good CB, Salone C, Aspinall SL. Comparison of hospitalization costs for the same adverse reaction associated with different medications. Am J Health Syst Pharm. 2023 Jun 7;80(12):750-755. doi: 10.1093/ajhp/zxad060. PMID: 36994836. (link)

Lu B, Wong M, Ha D, Bounthavong M, Banaei N, Deresinski S, Diep C. Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients. J Antimicrob Chemother. 2023 Apr 3;78(4):1009-1014. doi: 10.1093/jac/dkad037. PMID: 36879495; PMCID: PMC10068414. (link)

Sepassi A, Garcia S, Tanjasiri S, Lee S, Bounthavong M. Predicted Health Literacy Disparities Between Immigrant and US-Born Racial/Ethnic Minorities: a Nationwide Study. J Gen Intern Med. 2023 Aug;38(10):2364-2373. doi: 10.1007/s11606-023-08082-x. Epub 2023 Feb 27. PMID: 36849863; PMCID: PMC10406741. (link)

Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States. Pharmacoecon Open. 2023 May;7(3):393-404. doi: 10.1007/s41669-023-00398-y. Epub 2023 Feb 25. PMID: 36840894; PMCID: PMC10169956. (link)

Gustavson AM, Hagedorn HJ, Jesser LE, Kenny ME, Clothier BA, Bounthavong M, Ackland PE, Gordon AJ, Harris AHS. Healthcare quality measures in implementation research: advantages, risks and lessons learned. Health Res Policy Syst. 2022 Dec 7;20(1):131. doi: 10.1186/s12961-022-00934-y. PMID: 36476309; PMCID: PMC9730563. (link)

Fox E, Ha D, Bounthavong M, Meng L, Mui E, Holubar M, Deresinski S, Alegria W. Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. BMC Infect Dis. 2022 Nov 16;22(1):855. doi: 10.1186/s12879-022-07864-8. PMID: 36384497; PMCID: PMC9670444. (link)

Cucciare MA, Hagedorn HJ, Bounthavong M, Abraham TH, Greene CJ, Han X, Kemp L, Marchant K, White P, Humphreys K. Promoting benzodiazepine cessation through an electronically-delivered patient self-management intervention (EMPOWER-ED): Randomized controlled trial protocol. Contemp Clin Trials Commun. 2022 Sep 5;29:100994. doi: 10.1016/j.conctc.2022.100994. PMID: 36111174; PMCID: PMC9468353. (link)

Luli AJ, Morello CM, Lorentz SM, Bounthavong M, Brandl K, Hart LA. A Systematic Approach to Providing COVID-19 Vaccinations in the Community by Student Pharmacists. Pharmacy. 2022; 10(4):93. https://doi.org/10.3390/pharmacy10040093 (link)

Morello CM, Lai L, Chen C, Leung CM, Hirsch JD, Bounthavong M. Longitudinal Effects on Metabolic Biomarkers in Veterans 12 Months Following Discharge from Pharmacist-Provided Diabetes Care: A Retrospective Cohort Study. Pharmacy (Basel). 2022;10(3):63. Published 2022 Jun 13. doi:10.3390/pharmacy10030063 (link)

Sepassi A, Bounthavong M, Singh RF, Heyman M, Beizai K, Watanabe JH. Risk of Negative Health Outcomes and High Costs for People With Diabetes and Unmet Psychological Needs in the United States. Diabetes Spectr. 2022;35(2):207-215. doi:10.2337/ds21-0019 (link)

Wei R, Bounthavong M, Hill MB. High versus low dose oxytocin in lean and obese women: A double-blinded randomized controlled trial. Am J Obstet Gynecol MFM. 2022 Mar 28;100627. doi: 10.1016/j.ajogmf.2022.100627 (link)

Bounthavong M. Shayegani R, Manning JM, Marin J, Spoutz P, Hoffman JD, Harvey MA, Himstreet JD, Kay CL, Freeman BA, Grana A, Christopher MLD. Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks. Int J Med Inform. 2022 May;161:104712. doi: 10.1016/j.ijmedinf.2022.104712 (link)

Aspinall SL, Vu M, Moore V, Jiang R, Au A, Bounthavong M, Glassman PA. Estimated Costs of Severe Adverse Drug Reactions Resulting in Hospitalization in the Veterans Health Administration. JAMA Netw Open. 2022;5(2):e2147909. Published 2022 Feb 1. doi:10.1001/jamanetworkopen.2021.47909 (link)

Himstreet JE, Shayegani R, Spoutz P, Hoffman JD, Midboe AM, Hillman A, Marin J, Chen A, Smith JP, Manning J, Grana A, Gray C, Erhardt T, Garcia C, Freeman B, Christopher MLD, Bounthavong M. Implementation of a pharmacy-led virtual academic detailing program at the US Veterans Health Administration [published online ahead of print, 2022 Jan 27]. Am J Health Syst Pharm. 2022;zxac024. doi:10.1093/ajhp/zxac024 (link)

Hagedorn HJ, Gustavson AM, Ackland PE, Bangerter A, Bounthavong M, Clothier B, Harris A, Kenny ME, Noorbaloochi S, Salameh HA, Gordon AJ. Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities. J Gen Intern Med. 2022;1-9. doi:10.1007/s11606-021-07274-7 (link)

Li M, Bounthavong M. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018. J Manag Care Spec Pharm. 2021;27(12):1750-1756. doi:10.18553/jmcp.2021.27.12.1750 (link)

Bounthavong M, Christopher MLD, Veenstra DL, Basu A, Devine EB. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs [published online ahead of print, 2021 Nov 12]. J Pharm Pract. 2021;8971900211053282. doi:10.1177/08971900211053282 (link)

Bounthavong M, Suh K, Li M, Spoutz PM, Stottlemyer BA, Sepassi A. Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017. Subst Abuse Treat Prev Policy. 2021;16(1):80. Published 2021 Oct 20. doi:10.1186/s13011-021-00415-5 (link)

Hirsch JD, Kong N, Nguyen KT, Cadiz CL, Zhou C, Bajorek SA, Bounthavong M, Morello CM. Improved Patient-Reported Medication Adherence, Patient Satisfaction, and Glycemic Control in a Collaborative Care Pharmacist-Led Diabetes "Tune-Up" Clinic. Int J Environ Res Public Health. 2021;18(17):9242. Published 2021 Sep 1. doi:10.3390/ijerph18179242. (link)

Luli AJ, Awdishu L, Hirsch JD, Watanabe JH, Bounthavong M, Morello CM. Transferring Key Success Factors from Ambulatory Care into the Community Pharmacy in the United States. Pharmacy (Basel). 2021;9(3):116. Published 2021 Jun 23. doi:10.3390/pharmacy9030116. (link)

Kazerooni R, Howard IM, Keener AM, Bounthavong M. Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems. Clinicoecon Outcomes Res. 2021;13:603-609. Published 2021 Jun 30. doi:10.2147/CEOR.S320212. (link)

Eisman AB, Quanbeck A, Bounthavong M, Panattoni L, Glasgow RE. Implementation science issues in understanding, collecting, and using cost estimates: a multi-stakeholder perspective. Implement Sci. 2021;16(1):75. Published 2021 Aug 3. doi:10.1186/s13012-021-01143-x. (link)

Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, Goldhaber-Fiebert JD, Asch SM, Brandeau ML, Owens DK. Cost-Effectiveness of treatments for opioid use disorder: A model-based analysis. JAMA Psychiatry. 2021 Mar 31;e210247. doi: 10.1001/jamapsychiatry.2021.0247. (link)

Bounthavong M, Lau MK, Kay CL, Wells DL, Popish SJ, Harvey MA, Himstreet JE, Grana A, Freeman BA, Morillo CM, Christopher MLD. Impact of implementing an academic detailing program on opioid-benzodiazepine co-prescribing trends at the U.S. Department of Veterans Affairs. Pain Med. 2021 Mar 22;pnaa475. doi: 10.1093/pm/pnaa475. (link)

Bounthavong M, Harvey MA, Wells DL, Himstreet JE, Lau MK, Kay CL, Popish SJ, Grana AG, Freeman BA, Morillo C, Mullins-Cunningham S, Christopher MLD. Impact of Academic Detailing on Opioid Prescribing at the Veterans Health Administration. J Clin Anesth Pain Manag. 2020;4(2):165-172. doi: 10.36959/377/349. (link)

Hoffman JD, Shayegani R, Spoutz PM, Hillman AD, Smith JP, Wells DL, Popish SJ, Himstreet JE, Manning JM, Bounthavong M, Christopher MLD. Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic. J Am Pharm Assoc. 2020 Nov-Dec;60(6):e95-e99. doi: 10.1016/j.japh.2020.06.028. (link)

Bounthavong M, Harvey MA, Kay CL, Lau MK, Wells DL, Himstreet JE, Popish SJ, Oliva EM, Christopher MLD. Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Department of Veterans Affairs. J Am Pharm Assoc. Jul-Aug 2020;60(4):639-646. doi: 10.1016/j.japh.2019.11.010. (link)

Luli AJ, Bounthavong M, Watanabe JH. Pharmacists on the front-line of solving a public health crisis: Increasing access to medications for opioid use disorder. J Am Pharm Assoc. Mar-Apr 2020;60(2):297-303. doi: 10.1016/j.japh.2019.10.014. (link)

Bounthavong M, Suh K, Christopher MLD, Veenstra DL, Basu A, Devine EB. Providers' perception of academic detailing on opioid overdose education and naloxone prescribing at the Veterans Health Administration: A qualitative assessment. Res Social Adm Pharm. 2020 Aug;16(8):1033-1040. doi: 10.1016/j.sapharm.2019.10.015. (link)

Ragan A, Bounthavong M, Brittain K, Aikens G, Mirk A. Academic detailing to reduce sedative-hypnotic prescribing in older veterans. J Pharm Pract. 2019 Aug 25:897190019870949. doi: 10.1177/0897190019870949. (link)

Li M, Bounthavong M. Medicare Beneficiaries, Especially Unsubsidized Minorities, Struggle to Pay for Prescription Drugs: Results from the Medicare Current Beneficiary Survey. J Gen Intern Med. 2019 Jul 24. doi: 10.1007/s11606-019-05204-2. (link)

Bounthavong M, Devine EB, Christopher MLD, Harvey MA, Veenstra DL, Basu A. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration. Health Serv Res. 2019 Jul 17. doi: 10.1111/1475-6773.13194. (link)

Gale RC, Yu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder LJ, Midboe AM. Comparison of Rapid vs In-Depth Qualitative Analytic Methods from a Process Evaluation of Academic Detailing in the Veterans Health Administration. Implementation Science. 2019 Feb 1;14(1):11. doi: 10.1186/s13012-019-0853-y. (link)

Lau MK, Bounthavong M, Kay CL, Harvey MA, Christopher MLD. Clinical dashboard use and development for academic detailing in the U.S. Department of Veterans Affairs. Journal of the American Pharmacists Association. 2019 Mar - Apr;59(2S):S96-S103.e3. doi: 10.1016/j.japh.2018.12.006. (link)

Bounthavong M, Lau MK, Kay CL, Wells DL, Himstreet JE, Harvey MA, Popish SJ, Christopher MLD. Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder. Subst Abus. 2019 Mar 14:1-9. doi: 10.1080/08897077.2019.1573777. (link)

Bounthavong M, Butler J, Dolan CM, Dunn JD, Fisher KA, Oestreicher N, Pitt B, Hauptman PJ, Veenstra DL. A cost-effectiveness analysis of patiromer and spironolactone therapy in heart failure patients. Pharmacoeconomics. 2018 Dec;36(12):1463-1473. doi: 10.1007/s40273-018-0709-3. (link)

Mendes MAS, Smith JP, Marin J, Gray D, Bounthavong M, Lau MK, Miranda JL, Hauser P. A Direct-to-Consumer (DTC) educational quality improvement initiative to reduce benzodiazepine prescribing in older veterans. Federal Practitioner. 2018 September;35(9):36-43. (link)

Midboe AM, Wu J, Erhardt T, Carmichael JM, Bounthavong M, Christopher MLD, & Gale R. Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation. Pain Medicine. 2018 Sep 1;19(suppl_1):S46-S53. doi: 10.1093/pm/pny085. (link)

Patel S, Carmichael JM, Taylor JM, Bounthavong M, Higgins DT. Evaluating the Impact of a Clinical Decision Support Tool to Reduce Chronic Opioid Dose and Decrease Risk Classification in a Veteran Population. Ann Pharmacother. 2018 Apr;52(4):325-331. doi: 10.1177/1060028017739388. (link)

Oliva EM, Christopher ML, Wells D, Bounthavong M, Harvey M, Himstreet J, Emmendorfer T, Valentino M, Franchi M, Goodman F, Trafton JA; Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. J Am Pharm Assoc. 2017 Mar - Apr;57(2S):S168-S179.e4. doi: 10.1016/j.japh.2017.01.022. (link)

Bounthavong M, Harvey M, Wells D, Popish S, Himstreet J, Oliva E, Kay C, Lau MK, Randeria P, Phillips A, Christopher MLD. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis. J Am Pharm Assoc. 2017 Mar - Apr;57(2S):S68-S72. doi: 10.1016/j.japh.2016.11.003. PMID: 28089521. (link)

Hirsch JD, Bounthavong M, Arjmand A, Ha DR, Cadiz CL, Zimmerman A, Ourth H, Morreale AP, Edleman SV, Morello CM. Estimated Cost Effectiveness and Risk Reduction Associated with a Pharmacist-Led Diabetes Intense Medical Management ”Tune Up” Clinic. J Manag Care Spec Pharm. 2017 Mar;23(3):318-326. doi: 10.18553/jmcp.2017.23.3.318. PMID: 28230459. (link)

Jelacic S, Craddick K, Nair BG, Bounthavong M, Yeung K, Kusulos D, Knutson JA, Somani S, Bowdle A. Relative Costs of Anesthesiologist-Prepared, Hospital Pharmacy-Prepared and Outsourced Anesthesia Drugs. J Clin Anesth. 2017 Feb;36:178-183. doi: 10.1016/j.jclinane.2016.10.015. PMID: 28183562. (link)

Bounthavong M, Pruitt L, Smolenski D, Gahm G, Bansal A, Hansen R. Economic evaluation of Home-Based TeleBehavioral Health compared to In-Person treatment delivery for depression. J Telemed Telecare. 2018 Feb;24(2):84-92. doi: 10.1177/1357633X16678147. (link)

Bounthavong M, Li M, Watanabe JH. An evaluation of health care expenditures in Crohn’s disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Res Social Adm Pharm. 2017 May - Jun;13(3):530-538. doi: 10.1016/j.sapharm.2016.05.042. (link)

Wong SF, Bounthavong M, Nguyen C, Bechtoldt K, Lee E, Chen TC. Outcome Assessments and Cost Avoidance of a Comprehensive Oral Chemotherapy Management Clinic. J Natl Compr Canc Netw. 2016 Mar;14(3):279-85. (link)

Bounthavong M, Watanabe JH, Sullivan K. Approach to addressing missing data for electronic medical records and pharmacy claims research. Pharmacotherapy. 2015 Apr;35(4):380-7. doi: 10.1002/phar.1569. (link)

Watanabe JH, Chen T, Bounthavong M, Hsu JC. Consideration of New Guidelines for Cholesterol Reduction: Comparison of Lipid Reduction Threshold Achievement by ACC/AHA Benefit Groups. International Library of Diabetes and Metabolism. 2015;1(1):13-16. (link)

Kazerooni R, Nguyen JB, Bounthavong M, Tran MH, Madkour N. New start versus continuing users on aripiprazole: Implications for policy. Am J Manag Care. 2015;21(1):e43-e50. (link)

Sakharkar P, Bounthavong M, Hirsch JD, Morello CM, Chen TC, Law AV. Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services. Res Social Adm Pharm. 2015 Jul-Aug;11(4):487-98. doi: 10.1016/j.sapharm.2014.10.006. PMID: 25481330. (link)

Bounthavong M, Tran JN, Golshan S, Piland NF, Morello CM, Blickensderfer A, Best JH. Retrospective cohort study evaluating exenatide twice daily and long-acting insulin analogs in a Veterans Health Administration population with type 2 diabetes. Diabetes Metab. 2014 Sep;40(4):284-91. doi: 10.1016/j.diabet.2014.06.002. PMID: 25059703. (link)

Bounthavong M, Madkour N, Kazerooni R. Retrospective cohort study of anti-tumor necrosis factor agent use in a Veteran population. PeerJ. 2014 May 22;2:e385. doi: 10.7717/peerj.385. PMID: 24883246. (link)

Chen TC, Christofferson DE, Hamlett-Berry M, Kazerooni R, Bounthavong M, Bodie L, Myers M. A tobacco cessation treatment model using telehealth: a pilot evaluation in Veterans. J Telemed Telecare. 2014 Apr;20(3):161-3. doi: 10.1177/1357633X14527707. PMID: 24643952. (link)

Wong SF, Bounthavong M, Nguyen C, Bectoldt K, Hernandez E. Implementing a comprehensive oral chemotherapy management clinic: a pilot outcome report. Am J Health Syst Pharm. 2014 Jun 1;71(11):960-5. doi: 10.2146/ajhp130278. PMID: 24831001. (link)

Watanabe JH, Kazerooni R, Bounthavong M. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study. J Manag Care Pharm. 2014;20(1):43-50. PMID: 24372459. (link)

Chen TC, Kazerooni K, Vannort EM, Nguyen K, Nguyen S, Harris J, Bounthavong M. Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population. Health Promot Pract. 2013 Nov 14;15(4):512-520. PMID: 24231631. (link)

Kazerooni R, Bounthavong M, Watanabe JH. Association of copayment and statin adherence stratified by socioeconomic status. Ann Pharmacother. 2013;47(11):1463-70. doi: 10.1177/1060028013505743. PMID: 24259605. (link)

Hong MC, Hsu DI, Bounthavong M. Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and 𝛽-lactamase inhibitor combination. Infect Drug Resist. 2013;6:215-223. doi: 10.2147/IDR.S36140. PMID: 24348053. (link)

Kazerooni R, Watanabe JH, Bounthavong M. Association between statin adherence and cholesterol level reduction from baseline in a veteran population. Pharmacotherapy. 2013;33(10):1044-52. doi: 10.1002/phar.1305. PMID: 23744794. (link)

Watanabe JH, Chen TC, Ney JP, Bounthavong M. Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study. Ann Pharmacother. 2013;47(10):1253-59. doi: 10.1177/1060028013502000. PMID: 24259688. (link)

Watanabe JH, Chen TC, Bounthavong M. Revisiting the medication possession ratio threshold for adherence in lipid management. Curr Med Res Opin. 2013 Mar;29(3):175-80. doi: 10.1185/03007995.2013.766164. PMID: 23320610. (link)

Bounthavong M, Hsu DI. Pharmacoeconomic review of linezolid in Methicillin-resistant skin and soft tissue infections. Expert Rev Pharmacoecon Outcomes Res. 2012;12(6):683-98. doi: 10.1586/erp.12.72. PMID: 23252352. (link)

Nguyen CM, Bounthavong M, Mendes MAS, Christopher MLD, Tran JN, Kazerooni R, Morreale AP. Cost-utility analysis of tumor necrosis factor-alpha inhibitors for rheumatoid arthritis: An application of Bayesian methods for evidence synthesis in a Markov model. Pharmacoeconomics. 2012 Jul 1;30(7):575-93. doi: 10.2165/11594990-000000000-00000. Review. Erratum in: Pharmacoeconomics. 2012 Nov 1;30(11):1096. PMID: 22640174. (link)

Kazerooni R, Bounthavong M, Tran JN, Boggie DT, Meyer RS. Retrospective evaluation of inpatient celecoxib use after total hip and knee arthroplasty at a Veterans Affairs medical center. J Arthroplasty 2012;27(6):1033-40. doi: 10.1016/j.arth.2012.01.020. PMID: 22386610. (link)

Patel JJ, Mendes MAS, Bounthavong M, Christopher MLD, Boggie DT, Morreale AP. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model. J Eval Clin Pract 2012;18(2):247-255. doi: 10.1111/j.1365-2753.2010.01546.x. PMID: 20846318. (link)

Bounthavong M, Zargarzadeh A, Hsu DI, Vanness DJ. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus complicated skin and skin structure infection using Bayesian methods for evidence synthesis. Value Health 2011;14(5):631-9. doi: 10.1016/j.jval.2010.12.006. PMID: 21839399. (link)

Bach TH, Hsu DI, Bounthavong M. Present and emerging therapies for skin and soft tissue infections: focus on iclaprim. Clinical Medicine Reviews in Therapeutics 2011;3:191-201. (link)

Bounthavong M, Kazerooni R, Tran JN, Nguyen CM, Christopher MLD, Mendes MAS. Biologics: What solutions do we have for their high costs? California Pharmacist 2011;58(2):38-45. (link)

Law AV, Jackevicius C, Bounthavong M. Monographs as an integrative application of Evidence Based-Medicine and Pharmacoeconomics in the PharmD Curriculum. Am J Pharm Educ 2011;10;75(1):1. PMID: 21451753. (link)

Pak S, Bounthavong M, Christopher MLD, Mendes MAS, Foster EB, Boggie DT, Lacro J, Morreale AP. Evaluation of therapeutic interchange from donepezil to galantamine extended-release. Am J Pharm Benefits. 2011;3(1):38-44. (link)

Bounthavong M, Christopher MLD, Mendes MAS, Foster EB, Johns ST, Lim L, Rubin LM, Patel J, Stewart A. Measuring patient satisfaction in the Pharmacy Specialty Immunization Clinic (PSIC): a pharmacist-run immunization clinic at the Veterans Affairs San Diego Healthcare System (VASDHS). Int J Pharm Pract 2010;18:100-7. PMID: 20441119. (link)

Kazerooni R, Bounthavong M. Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery. Clinicoecon Outcomes Res 2010;2:15-23. PMID: 21935311. (link)

Bounthavong M, Hsu DI. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infections (cSSTI): a meta-analysis. Curr Med Res Opin 2010;26:407-21. doi: 10.1185/03007990903454912. PMID: 20001574. (link)

Aldridge V, Park H, Bounthavong M, Morreale AP. Implementing a Comprehensive Emergency Department Pharmacist Program. Am J Health Syst Pharm 2009;66:1943-7. doi: 10.2146/ajhp080660. PMID: 19850790. (link)

Bounthavong M, Hsu DI, Okamoto MP. Cost-effectiveness analysis of linezolid versus vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI) using a decision analytic model. Int J Clin Pract 2009;63:376-86. doi: 10.1111/j.1742-1241.2008.01958.x. PMID: 19222624. (link)

Bounthavong M, Law AV. Identifying health-related quality of life (HRQL) domains for multiple chronic conditions (diabetes, hypertension, and dyslipidemia): patient and provider perspectives. J Eval Clin Pract 2008;14:1002-12. doi: 10.1111/j.1365-2753.2007.00933.x. PMID: 18759755. (link)

Bounthavong M, Okamoto MP. Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine, and haloperidol in the treatment of schizophrenia. J Eval Clin Pract 2007;13:453-60. PMID: 17518814. (link)